tm
Seeing Is Believing
tm
Seeing Is Believing
YMAB is currently covered by 8 analysts with an average price target of $20.91. This is a potential upside of $5.62 (36.76%) from yesterday's end of day stock price of $15.29.
Y mAbs Therapeutics's activity chart (see below) currently has 11 price targets and 35 ratings on display. The stock rating distribution of YMAB is 62.07% BUY, 24.14% HOLD and 13.79% SELL.
Analysts average stock forecasts to be materialized ratio is 59.58% with an average time for these price targets to be met of 162.88 days.
Highest price target for YMAB is $26, Lowest price target is $5, average price target is $20.91.
Most recent stock forecast was given by ETZER DAROUT from BMO on 04-Mar-2024. First documented stock forecast 05-May-2020.
Currently out of the existing stock ratings of YMAB, 18 are a BUY (62.07%), 7 are a HOLD (24.14%), 4 are a SELL (13.79%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
26
$10.84 (71.50%)
15
1 months 20 days ago
3/5 (60%)
$8.67 (50.03%)
367
Buy
21
$5.84 (38.52%)
11
2 months 4 days ago
3/5 (60%)
$4.45 (26.89%)
178
Hold
10
$-5.16 (-34.04%)
12
5 months 9 days ago
3/3 (100%)
$4.75 (90.48%)
114
Sell
7
$-8.16 (-53.83%)
7
8 months 2 days ago
2/5 (40%)
$0.71 (11.29%)
149
Sell
5
$-10.16 (-67.02%)
8 months 10 days ago
3/4 (75%)
$-0.62 (-11.03%)
248
What is YMAB (Y mAbs Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on YMAB (Y mAbs Therapeutics) with a proven track record?
Which analyst has the current lower performing score on YMAB (Y mAbs Therapeutics) with a proven track record?
Which analyst has the most public recommendations on YMAB (Y mAbs Therapeutics)?
Which analyst is the currently most bullish on YMAB (Y mAbs Therapeutics)?
Which analyst is the currently most reserved on YMAB (Y mAbs Therapeutics)?
